Literature DB >> 9401168

Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.

S L Mercer1, V Goel, I G Levy, F D Ashbury, D C Iverson, N A Iscoe.   

Abstract

Despite controversy about prostate cancer screening, administrative data show that the use of prostate specific antigen (PSA) testing in Canada has increased. This study sought to determine awareness and knowledge of prostate cancer and screening, use to date, and future intentions to have a digital rectal examination (DRE) and PSA test among Canadian men aged 40 and over. Data were collected through a Canada-wide cross-sectional random digit dial telephone survey of 629 men. Awareness of DRE and PSA, use to date, and future intended use varied with age and education. Although only 9% of respondents had had PSA testing for screening, future intentions to undergo this test were higher than use to date. Knowledge of prostate cancer and screening controversies was low, and men received more information about PSA from the media than from doctors. Men would, therefore, benefit from age- and education-specific information regarding the factors to consider in making an informed choice about prostate cancer screening.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401168

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  9 in total

1.  Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.

Authors:  P S Bunting; V Goel; J I Williams; N A Iscoe
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

2.  Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.

Authors:  M D Krahn; A Coombs; I G Levy
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

Review 3.  Prostate-specific antigen in the early detection of prostate cancer.

Authors:  Ian M Thompson; Donna P Ankerst
Journal:  CMAJ       Date:  2007-06-19       Impact factor: 8.262

4.  Why don't family physicians follow clinical practice guidelines for cancer screening? Family Physician Study Group, Sociobehavioral Cancer Research Network, National Cancer Institute of Canada.

Authors:  F Tudiver; C Herbert; V Goel
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 5.  Current status of PSA screening. Early detection of prostate cancer.

Authors:  Tom Pickles
Journal:  Can Fam Physician       Date:  2004-01       Impact factor: 3.275

Review 6.  Prostate cancer: 1. The descriptive epidemiology in Canada.

Authors:  I G Levy; N A Iscoe; L H Klotz
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

7.  Lack of comprehension of common prostate cancer terms in an underserved population.

Authors:  Kerry L Kilbridge; Gertrude Fraser; Murray Krahn; Elizabeth M Nelson; Mark Conaway; Randall Bashore; Andrew Wolf; Michael J Barry; Debra A Gong; Robert F Nease; Alfred F Connors
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

8.  Factors related to use of prostate cancer screening: the Alberta Tomorrow Project.

Authors:  Harriet Richardson; Kristan J Aronson; Alison James; Elizabeth S McGregor; Heather Bryant
Journal:  Open Med       Date:  2007-04-14

9.  Predictors of participation in risk-based prostate cancer screening.

Authors:  Marie Koitsalu; Martin Eklund; Jan Adolfsson; Mirjam A G Sprangers; Henrik Grönberg; Yvonne Brandberg
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.